{"name":"Bio 54, LLC","slug":"bio-54-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BXP154B","genericName":"BXP154B","slug":"bxp154b","indication":"Other","status":"phase_2"},{"name":"BXP154","genericName":"BXP154","slug":"bxp154","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BXP154B","genericName":"BXP154B","slug":"bxp154b","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BXP154","genericName":"BXP154","slug":"bxp154","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNZUZSdzFDTXh0M0FqMFNHZXhDdFNYNk42b2NBX2pDcDJJNExmMW43dnNhWF94M0p6NkVHQ2o0Yzh0NDYzTkxGanQtbTRzOFctazN5WmpfVnN1SUdyQzZYcDFyMVRXVTZ1VmExbXpuRjJLbHk5QlZZc3pPUUt3WDZ3NVhIbEdPQVVRUUtZU214YzNIc0hWdHd2Y21yamR6VTcyN0tzZ3VuQk1IYmN1TXc5VXFoZUdMMlhuNmJGUUo0V2tiX0ZGeFVtRjRRdTFOSElhRWZCdkJjWGVBeVF4TkkxOWdBU1RVdVZkUUV6ZFVMRFltU0tfT3hyTnp2Zw?oc=5","date":"2023-12-19","type":"pipeline","source":"BioSpace","summary":"Alora Pharmaceuticals, LLC announces the availability of Once-Daily Relexxii® for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) - BioSpace","headline":"Alora Pharmaceuticals, LLC announces the availability of Once-Daily Relexxii® for the treatment of Attention Deficit Hyp","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}